Product Center
From the perspective of the total number of affected individuals, the pediatric drug market holds significant untapped potential. Notably, approximately 85% of children suffer from respiratory and digestive system diseases—conditions that not only account for the largest proportion of pediatric illnesses but also tend to occur frequently and often recur. Looking at the age distribution of patients discharged in 2012, intestinal infectious diseases, upper respiratory tract infections, lower respiratory tract infections (such as pneumonia), and influenza collectively accounted for 65%, 79.7%, 75.5%, and 66.9% of children, respectively. As a well-known pediatric brand and trusted expert in pediatric medications, the Hailongwa series is dedicated to providing comprehensive care for your child’s health!